Great post, nothing to add except for the M&A info you requested. Having looked again at the numbers the acquisitions were a bit lower than I had stated, but still around 15x higher than the current valuation of EYE
In 2022:
Alcon acquired Ivantis' Hydrus device for an upfront payment of AU$710m plus undisclosed contingent payments. Hydrus has been approved in the US since 2018 and has been used in over 85,000 procedures (legacy iTrack has been used in over 100,000 procedures and has been around far longer)
Abbie acquired iSTAR for a $100m + contingent payments of up to $710m. iSTAR is a clinical stage company developing MINIject, a MIGS device that is still only enrolling for a US PMA study to commercialise their device (so no long term data either)
- Forums
- ASX - By Stock
- Nova Eye Medical (EYE) Discussion
Great post, nothing to add except for the M&A info you...
-
-
- There are more pages in this discussion • 2,351 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $44.66M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 19.5¢ | $9.907K | 50.65K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65104 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 51773 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 65104 | 0.195 |
3 | 202141 | 0.190 |
1 | 20980 | 0.185 |
2 | 71691 | 0.180 |
5 | 114937 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 51773 | 2 |
0.205 | 44282 | 2 |
0.210 | 223212 | 2 |
0.215 | 304291 | 5 |
0.230 | 103718 | 2 |
Last trade - 13.43pm 13/09/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online